Cargando…
STAT activation status differentiates leukemogenic from non-leukemogenic stem cells in AML and is suppressed by arsenic in t(6;9)-positive AML
Acute myeloid leukemia (AML) is characterized by an aberrant self-renewal of hematopoietic stem cells (HSC) and a block in differentiation. The major therapeutic challenge is the characterization of the leukemic stem cell as a target for the eradication of the disease. Until now the biology of AML-a...
Autores principales: | Oancea, Claudia, Rüster, Brigitte, Brill, Boris, Roos, Jessica, Heinssmann, Maria, Bug, Gesine, Mian, Afsar Ali, Guillen, Nathalie Andrea, Kornblau, Steven M., Henschler, Reinhard, Ruthardt, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4279436/ https://www.ncbi.nlm.nih.gov/pubmed/25568664 |
Ejemplares similares
-
Reciprocal t(9;22) ABL/BCR Fusion Proteins: Leukemogenic Potential and Effects on B Cell Commitment
por: Zheng, Xiaomin, et al.
Publicado: (2009) -
Redox metabolism maintains the leukemogenic capacity and drug resistance of AML cells
por: Huang, Dan, et al.
Publicado: (2023) -
Epidemiological studies of the leukemogenic effects of radiation.
por: Lilienfeld, A. M.
Publicado: (1966) -
The Leukemogenic Action of Estrogens in Hybrid Mice
por: Gardner, W. U., et al.
Publicado: (1944) -
DNA microarray expression profiling of a new t(8;13) AML case allows identification of possible leukemogenic transformation markers
por: Pozzo, Aline Rangel, et al.
Publicado: (2017)